Literature DB >> 17961018

Evaluation and management of Cushing syndrome in cases of negative sellar magnetic resonance imaging.

Jay Jagannathan1, Jason P Sheehan, John A Jane.   

Abstract

The treatment of patients with Cushing disease and without magnetic resonance (MR) imaging evidence of Cushing disease (that is, negative MR imaging) is discussed in this paper. Magnetic resonance imaging is the diagnostic modality of choice in Cushing disease, but in up to 40% of these patients negative imaging can be caused by tumor-related factors and limitations in imaging techniques. In cases in which the MR imaging is negative, it is critical to make sure that the diagnosis of Cushing disease is correct. This can be accomplished by performing a complete laboratory and imaging workup, including dexamethasone suppression tests, imaging of the adrenal glands, and inferior petrosal sinus sampling when appropriate. If these evaluations suggest a pituitary source of the hypercortisolemia, then transsphenoidal surgery remains the treatment of choice. The authors favor the endoscopic approach because it gives a wider and more magnified view of the sella and allows inspection of the medial cavernous sinus walls. Radiosurgery is an effective treatment option in patients with persistent Cushing disease. When a target cannot be found on MR imaging, one can target the entire sellar region with radiosurgery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17961018     DOI: 10.3171/foc.2007.23.3.4

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  8 in total

1.  Selective inferior petrosal sinus sampling without venous outflow diversion in the detection of a pituitary adenoma in Cushing's syndrome.

Authors:  Lukas Andereggen; Gerhard Schroth; Jan Gralla; Rolf Seiler; Luigi Mariani; Jürgen Beck; Hans-Rudolf Widmer; Robert H Andres; Emanuel Christ; Christoph Ozdoba
Journal:  Neuroradiology       Date:  2011-08-02       Impact factor: 2.804

2.  Factors affecting early versus late remission in acromegaly following stereotactic radiosurgery.

Authors:  Mohana Rao Patibandla; Zhiyuan Xu; Jason P Sheehan
Journal:  J Neurooncol       Date:  2018-02-07       Impact factor: 4.130

3.  Surgical outcome of transsphenoidal surgery in Cushing's disease: a case series of 1106 patients from a single center over 30 years.

Authors:  Congxin Dai; Ming Feng; Bowen Sun; Xinjie Bao; Yong Yao; Kan Deng; Zuyuan Ren; Binghao Zhao; Lin Lu; Renzhi Wang; Jun Kang
Journal:  Endocrine       Date:  2021-08-20       Impact factor: 3.633

Review 4.  Surgical strategies in the treatment of MR-negative Cushing's Disease: a systematic review and treatment algorithm.

Authors:  Andrew B Yang; Fraser Henderson; Theodore H Schwartz
Journal:  Pituitary       Date:  2022-06-16       Impact factor: 3.599

5.  MRI-negative Cushing's Disease: Management Strategy and Outcomes in 15 Cases Utilizing a Pure Endoscopic Endonasal Approach.

Authors:  Guive Sharifi; Amir Arsalan Amin; Mohammadmahdi Sabahi; Nikolas B Echeverry; Nader Akbari Dilmaghani; Seyed Ali Mousavinejad; Majid Valizadeh; Zahra Davoudi; Badih Adada; Hamid Borghei-Razavi
Journal:  BMC Endocr Disord       Date:  2022-06-09       Impact factor: 3.263

Review 6.  Cushing's disease.

Authors:  Frederic Castinetti; Isabelle Morange; Bernard Conte-Devolx; Thierry Brue
Journal:  Orphanet J Rare Dis       Date:  2012-06-18       Impact factor: 4.123

7.  Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI.

Authors:  Sven Berkmann; Michel Roethlisberger; Beat Mueller; Mirjam Christ-Crain; Luigi Mariani; Egbert Nitzsche; Freimut Juengling
Journal:  Pituitary       Date:  2021-06-21       Impact factor: 4.107

8.  Diagnosis and Multimodality Management of Cushing's Disease: A Practical Review.

Authors:  Gabriel Zada
Journal:  Int J Endocrinol       Date:  2013-01-15       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.